These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29932244)
1. Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma. Kiyuna T; Tome Y; Murakami T; Zhao M; Miyake K; Igarashi K; Kawaguchi K; Miyake M; Oshiro H; Higuchi T; Li Y; Dry SM; Nelson SD; Russell TA; Eckardt MA; Singh AS; Kanaya F; Eilber FC; Hoffman RM J Cell Biochem; 2018 Sep; 119(9):7827-7833. PubMed ID: 29932244 [TBL] [Abstract][Full Text] [Related]
2. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model. Kiyuna T; Tome Y; Murakami T; Kawaguchi K; Igarashi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Elliott I; Singh SR; Kanaya F; Eilber FC; Hoffman RM BMC Cancer; 2018 Aug; 18(1):840. PubMed ID: 30126369 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model. Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Singh SR; Kanaya F; Eilber FC; Hoffman RM Tissue Cell; 2018 Aug; 53():30-36. PubMed ID: 30060824 [TBL] [Abstract][Full Text] [Related]
4. Recombinant Methioninase Combined With Tumor-targeting Igarashi K; Kawaguchi K; Zhao M; Han Q; Tan Y; Kiyuna T; Miyake K; Higuchi T; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM Anticancer Res; 2020 May; 40(5):2515-2523. PubMed ID: 32366396 [TBL] [Abstract][Full Text] [Related]
5. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model. Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519 [TBL] [Abstract][Full Text] [Related]
6. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago. Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559 [TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model. Murakami T; DeLong J; Eilber FC; Zhao M; Zhang Y; Zhang N; Singh A; Russell T; Deng S; Reynoso J; Quan C; Hiroshima Y; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Chawla S; Endo I; Hoffman RM Oncotarget; 2016 Mar; 7(11):12783-90. PubMed ID: 26859573 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models. Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM Biochem Biophys Res Commun; 2018 Mar; 497(4):1055-1061. PubMed ID: 29481803 [TBL] [Abstract][Full Text] [Related]
9. A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model. Kiyuna T; Tome Y; Murakami T; Miyake K; Igarashi K; Kawaguchi K; Oshiro H; Higuchi T; Miyake M; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Chawla S; Kanaya F; Eilber FC; Singh SR; Zhao M; Hoffman RM Biochem Biophys Res Commun; 2018 Nov; 505(3):733-739. PubMed ID: 30292411 [TBL] [Abstract][Full Text] [Related]
10. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model. Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664 [TBL] [Abstract][Full Text] [Related]
11. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide. Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068 [TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP). Miyake K; Kiyuna T; Miyake M; Zhao M; Wangsiricharoen S; Kawaguchi K; Zhang Z; Higuchi T; Razmjooei S; Li Y; Nelson SD; Russell T; Singh A; Murakami T; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Chawla SP; Eilber FC; Endo I; Hoffman RM Tissue Cell; 2018 Oct; 54():144-149. PubMed ID: 30309504 [TBL] [Abstract][Full Text] [Related]